BlackRock Health Sciences Trust (NYSE:BME) Sees Significant Decline in Short Interest

BlackRock Health Sciences Trust (NYSE:BME) saw a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 12,700 shares, a decrease of 15.9% from the February 28th total of 15,100 shares. Based on an average trading volume of 53,600 shares, the short-interest ratio is currently 0.2 days.

BlackRock Health Sciences Trust Price Performance

Shares of BlackRock Health Sciences Trust stock traded up $0.11 during mid-day trading on Wednesday, reaching $38.46. 34,307 shares of the stock traded hands, compared to its average volume of 39,694. The business has a 50-day moving average of $39.83 and a 200 day moving average of $39.92. BlackRock Health Sciences Trust has a fifty-two week low of $36.87 and a fifty-two week high of $42.64.

BlackRock Health Sciences Trust Dividend Announcement

The business also recently announced a monthly dividend, which was paid on Monday, March 31st. Shareholders of record on Friday, March 14th were issued a $0.2621 dividend. This represents a $3.15 annualized dividend and a yield of 8.18%. The ex-dividend date of this dividend was Friday, March 14th.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Raymond James Financial Inc. acquired a new position in shares of BlackRock Health Sciences Trust in the 4th quarter worth approximately $3,250,000. Wolverine Asset Management LLC lifted its stake in BlackRock Health Sciences Trust by 29.1% during the fourth quarter. Wolverine Asset Management LLC now owns 110,493 shares of the company’s stock worth $4,191,000 after purchasing an additional 24,928 shares in the last quarter. AlphaStar Capital Management LLC purchased a new position in BlackRock Health Sciences Trust during the 4th quarter valued at about $878,000. Hara Capital LLC purchased a new position in shares of BlackRock Health Sciences Trust in the fourth quarter valued at approximately $832,000. Finally, Invesco Ltd. boosted its position in BlackRock Health Sciences Trust by 8.9% in the 4th quarter. Invesco Ltd. now owns 223,316 shares of the company’s stock valued at $8,470,000 after buying an additional 18,213 shares during the period.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.